NCT03386656View on ClinicalTrials.gov

Efficacy and Safety of Topical Application of Tranexamic Acid for Saving Blood Losses in Patients Subjected to Prosthetic Knee Surgery

PHASE3CompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

November 28, 2017

Primary Completion Date

May 1, 2019

Study Completion Date

May 8, 2019

Conditions

Osteoarthritis, Knee

Interventions

DRUG

Amchafibrin

Tranexamic acid (Amchafibrin) exerts an antihemorrhagic activity by inhibiting the fibrinolytic properties of plasmin.

OTHER

Saline Solution

Placebo

Trial Locations (1)

11009

Hospital Universitario Puerta del Mar, Cadiz

All Listed Sponsors

lead

Fundación Pública Andaluza Progreso y Salud

OTHER

NCT03386656 - Efficacy and Safety of Topical Application of Tranexamic Acid for Saving Blood Losses in Patients Subjected to Prosthetic Knee Surgery | Biotech Hunter | Biotech Hunter